Seeing Is Believing
Currently out of the existing stock ratings of Biren Amin, 38 are a HOLD (19.59%), 155 are a BUY (79.9%), 1 are a SELL (0.52%).
Analyst Biren Amin, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 56.61% that have a potential upside of 31.68% achieved within 283 days. Previously, Biren Amin worked at JEFFERIES.
Biren Amin’s has documented 382 price targets and ratings displayed on 49 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 29-Jul-2025.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$23
$18.86 (455.56%)
$25
28 days ago
(09-Sep-2025)
5/11 (45.45%)
$18.17 (376.19%)
264
Buy
$11
$6.86 (165.70%)
$18
10 months 20 days ago
(17-Nov-2024)
2/4 (50%)
$8.37 (318.25%)
96
Buy
$5
$0.86 (20.77%)
$7.85
1 years 6 months 20 days ago
(17-Mar-2024)
2/2 (100%)
$-5.59 (-52.79%)
207
Buy
$8.15
$4.01 (96.86%)
$8.15
2 years 6 months 10 days ago
(27-Mar-2023)
3/3 (100%)
$-20.9 (-71.94%)
465
Buy
$6.87
$5.74 (507.96%)
4 years 6 months 22 days ago
(16-Mar-2021)
0/1 (0%)
$3.72 (118.10%)
Which stock is Biren Amin is most bullish on?
Which stock is Biren Amin is most reserved on?
What Year was the first public recommendation made by Biren Amin?